Search Results - "Soltan, Osama M."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives by Shaykoon, Montaser Sh, Marzouk, Adel A., Soltan, Osama M., Wanas, Amira S., Radwan, Mohamed M., Gouda, Ahmed M., Youssif, Bahaa G.M., Abdel-Aziz, Mohamed

    Published in Bioorganic chemistry (01-07-2020)
    “…[Display omitted] •Two series of 1,2,4-triazole and 1,3,4-oxadiazole derivatives were designed and synthesized.•3a-b and 4a-b showed higher antitrypanosomal…”
    Get full text
    Journal Article
  3. 3

    Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy by Soltan, Osama M., Shoman, Mai E., Abdel-Aziz, Salah A., Narumi, Atsushi, Konno, Hiroyuki, Abdel-Aziz, Mohamed

    Published in European journal of medicinal chemistry (05-12-2021)
    “…Protein kinases have grown over the past few years as a crucial target for different cancer types. With the multifactorial nature of cancer, and the fast…”
    Get full text
    Journal Article
  4. 4

    Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation by Soltan, Osama M., Abdel-Aziz, Salah A., Sh. Shaykoon, Montaser, Osawa, Keima, Narumi, Atsushi, Abdel-Aziz, Mohamed, Shoman, Mai E, Konno, Hiroyuki

    Published in Bioorganic & medicinal chemistry letters (01-04-2024)
    “…[Display omitted] •Synthesis and evaluation of 1,5-diarylpyrazole derivatives as potential dual inhibitors of EGFR/JNK-2 for possible anticancer activity.•5b…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy by Soltan, Osama M., Abdelrahman, Kamal S., Bass, Amr K.A., Takizawa, Kazuki, Narumi, Atsushi, Konno, Hiroyuki

    Published in Bioorganic chemistry (01-10-2024)
    “…[Display omitted] •The HDACs ability to synergistically boost the performance of other anti-AD drugs, as well as the ease with which HDACs inhibitor cap group,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation by El Hamd, Mohamed A., Soltan, Osama M., Abdelrahman, Kamal S., Alsaggaf, Wejdan T., Abu‐hassan, Ahmed A.

    Published in Luminescence (Chichester, England) (01-06-2023)
    “…Dipeptidyl peptidase‐4 enzyme suppressant is a unique category of oral antidiabetic medication. Sitagliptin (STG) is a perfect member of this category and is…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11